• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥马珠单抗的皮肤科应用标题

Dermatologic uses of omalizumabtitle.

作者信息

Chia Justin C, Mydlarski P Régine

机构信息

a Division of Dermatology, Department of Medicine , University of Calgary , Calgary , Alberta , Canada.

出版信息

J Dermatolog Treat. 2017 Jun;28(4):332-337. doi: 10.1080/09546634.2016.1249819. Epub 2016 Nov 7.

DOI:10.1080/09546634.2016.1249819
PMID:27759482
Abstract

PURPOSE

Omalizumab is a recombinant humanized monoclonal antibody that inhibits the binding of immunoglobulin E (IgE) to the high-affinity IgE receptor (FceRI) on the surface of mast cells and basophils. Omalizumab has been approved for use in asthma, and new reports show promise in a variety of dermatologic diseases. Herein, we review the literature on omalizumab in dermatology and discuss the safety, efficacy and mechanisms of action for this emerging therapy.

MATERIALS AND METHODS

PubMED, MEDLINE and Embase databases were searched for the period 1 January 1990 to 1 September 2016. Articles sourced were graded according to the Oxford Center for Evidence-Based Medicine Levels of Evidence Grades of Recommendation criteria.

RESULTS

A total of 99 articles met our inclusion criteria. They included reports on the use of omalizumab in chronic spontaneous urticaria, atopic dermatitis, mastocytosis, hyper-IgE syndrome, bullous pemphigoid, Netherton syndrome, urticarial vasculitis, Churg-Strauss syndrome and toxic epidermal necrolysis.

CONCLUSIONS

Omalizumab is effective in a variety of recalcitrant immune-mediated and autoimmune skin disorders. It is a safe and effective treatment for use in chronic idiopathic urticaria (Grade of recommendation: A). Randomized clinical trials with long-term follow-ups are warranted to firmly establish the role of omalizumab in the treatment of dermatologic disease.

摘要

目的

奥马珠单抗是一种重组人源化单克隆抗体,可抑制免疫球蛋白E(IgE)与肥大细胞和嗜碱性粒细胞表面的高亲和力IgE受体(FceRI)结合。奥马珠单抗已被批准用于哮喘治疗,新的报道显示其在多种皮肤病中也有应用前景。在此,我们综述奥马珠单抗在皮肤病学领域的文献,并探讨这种新兴疗法的安全性、有效性及作用机制。

材料与方法

检索了1990年1月1日至2016年9月1日期间的PubMed、MEDLINE和Embase数据库。根据牛津循证医学中心证据水平和推荐等级标准对所获文章进行分级。

结果

共有99篇文章符合我们的纳入标准。这些文章包括关于奥马珠单抗在慢性自发性荨麻疹、特应性皮炎、肥大细胞增多症、高IgE综合征、大疱性类天疱疮、Netherton综合征、荨麻疹性血管炎、Churg-Strauss综合征和中毒性表皮坏死松解症中的应用报道。

结论

奥马珠单抗在多种难治性免疫介导和自身免疫性皮肤病中有效。它是治疗慢性特发性荨麻疹的一种安全有效的疗法(推荐等级:A)。有必要进行长期随访的随机临床试验,以明确奥马珠单抗在皮肤病治疗中的作用。

相似文献

1
Dermatologic uses of omalizumabtitle.奥马珠单抗的皮肤科应用标题
J Dermatolog Treat. 2017 Jun;28(4):332-337. doi: 10.1080/09546634.2016.1249819. Epub 2016 Nov 7.
2
[Dermatological implications of omalizumab, an anti-IgE antibody].抗IgE抗体奥马珠单抗的皮肤学影响
Rev Med Suisse. 2015 Apr 1;11(468):779-80, 782-3.
3
[EFFECTIVE TREATMENT FOR BULLOUS PEMPHIGOID WITH OMALIZUMAB].[奥马珠单抗治疗大疱性类天疱疮的有效疗法]
Harefuah. 2020 Jan;159(1):29-30.
4
Efficacy and safety of omalizumab in paediatric age: an update of literature data.奥马珠单抗在儿童年龄段的疗效与安全性:文献数据更新
J Biol Regul Homeost Agents. 2016 Apr-Jun;30(2):579-84.
5
Treatment of chronic autoimmune urticaria with omalizumab.用奥马珠单抗治疗慢性自身免疫性荨麻疹。
J Allergy Clin Immunol. 2008 Sep;122(3):569-73. doi: 10.1016/j.jaci.2008.07.006.
6
IgE-Related Chronic Diseases and Anti-IgE-Based Treatments.IgE 相关的慢性疾病和抗 IgE 治疗方法。
J Immunol Res. 2016;2016:8163803. doi: 10.1155/2016/8163803. Epub 2016 Dec 21.
7
Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria.有助于奥马珠单抗治疗慢性自发性荨麻疹疗效的作用机制。
Allergy. 2017 Apr;72(4):519-533. doi: 10.1111/all.13083. Epub 2017 Jan 4.
8
Omalizumab for treating chronic spontaneous urticaria: an expert review on efficacy and safety.奥马珠单抗治疗慢性自发性荨麻疹:疗效与安全性专家综述
Expert Opin Biol Ther. 2017 Mar;17(3):375-385. doi: 10.1080/14712598.2017.1285903. Epub 2017 Feb 9.
9
Omalizumab for the Treatment of Chronic Idiopathic Urticaria: Systematic Review of the Literature.奥马珠单抗治疗慢性特发性荨麻疹:文献系统评价
Pharmacotherapy. 2017 Apr;37(4):464-480. doi: 10.1002/phar.1915. Epub 2017 Mar 23.
10
Omalizumab for atopic dermatitis: case series and a systematic review of the literature.奥马珠单抗治疗特应性皮炎:病例系列及文献系统评价
Int J Dermatol. 2017 Jan;56(1):18-26. doi: 10.1111/ijd.13353. Epub 2016 Jun 23.

引用本文的文献

1
Omalizumab as a Succesfull Therapy in Normocomplementemic Urticarial Vasculitis: A Series of Four Patients and Review of the Literature.奥马珠单抗成功治疗补体正常的荨麻疹性血管炎:4例病例系列及文献复习
Ann Dermatol. 2019 Jun;31(3):335-338. doi: 10.5021/ad.2019.31.3.335. Epub 2019 May 1.
2
Partial and Transient Clinical Response to Omalizumab in IL-21-Induced Low STAT3-Phosphorylation on Hyper-IgE Syndrome.奥马珠单抗对白细胞介素-21诱导的高IgE综合征中低STAT3磷酸化的部分和短暂临床反应
Case Reports Immunol. 2019 Jul 4;2019:6357256. doi: 10.1155/2019/6357256. eCollection 2019.
3
Platelets and IgE: Shaping the Innate Immune Response in Systemic Lupus Erythematosus.
血小板与 IgE:在系统性红斑狼疮中塑造固有免疫应答。
Clin Rev Allergy Immunol. 2020 Apr;58(2):194-212. doi: 10.1007/s12016-019-08744-x.